Brazil Bariatric Surgery Devices Market Analysis

Brazil Bariatric Surgery Devices Market Executive Summary

The Brazil Bariatric Surgery Devices Market is at around $66.5 Mn in 2023 and is projected to reach $101.3 Mn in 2030, exhibiting a CAGR of 6.2% during the forecast period 2023-2030.

Bariatric surgery is a medical procedure used to manage severe obesity and its associated health conditions. These surgical interventions aim to achieve substantial and sustained weight loss through various mechanisms, such as reducing stomach size, altering gut hormones, and limiting nutrient absorption. Bariatric surgery is considered a highly effective treatment, as it can lead to significant weight loss and improve numerous obesity-related health problems, including type 2 diabetes, high blood pressure, and sleep apnoea. The most common types of bariatric surgery include sleeve gastrectomy, Roux-en-Y gastric bypass, gastric banding, and duodenal switch. Patients typically qualify for these procedures if they have a body mass index (BMI) of 40 or higher, or a BMI of 35 to 39.9 with obesity-related health issues. While bariatric surgery can offer substantial benefits, it also carries potential short-term and long-term risks, such as bleeding, infection, nutritional deficiencies, and the need for revision surgery. Careful preparation, including lifestyle changes and medical evaluations, as well as long-term follow-up, are crucial to ensure the success and safety of these life-changing procedures.

Brazil stands as one of the countries with the highest obesity prevalence in the world. It was estimated that as of 2023 around a fifth of the population suffered from obesity. In 2023 the prevalence of Obesity and overweight is 24.3% and 61.4% respectively. Therefore, the market is driven by various factors such as increasing demand for minimally invasive surgeries, rising incidence of obesity, technological advancements, rising awareness about bariatric surgery.

The prominent players in the market are Bhio Supply, Medicone, Scitech Medical, Medtronic, B. Braun, Johnson & Johnson, Cousin Surgery among others.

Market Dynamics

Market Drivers

Increasing prevalence of Obesity: The previous few decades have seen a steady rise in the obesity prevalence in Brazil. As per Statista, the percentage of people who are overweight or obese in 2023 will be 61.4% and 24.3%, respectively. This pattern will persist, expanding the pool of candidates for bariatric procedures and stimulating the market for associated equipment.

Increasing rate of comorbidities associated to obesity: Hypertension is about twice as prevalent in men and women with obesity as in those with a normal weight. In Brazil, it was estimated that approximately 40.0% of diabetes cases are attributed to obesity, especially among women. Thus, the increasing rate comorbidities associated to obesity is driving the market of bariatric surgery devices market.

Technological developments: Surgical methods and equipment are always being improved, making bariatric treatments less intrusive, safer, and more successful. For instance, shorter recovery times and better surgical results are being achieved with the advent of sophisticated laparoscopic and robotic-assisted surgical devices.

Market Restraints

Expenses associated with bariatric surgeries and devices: Despite improvements in coverage, the high costs of bariatric procedures and devices is still a significant barrier for many patients. This is especially true for those without comprehensive insurance coverage or in provinces with limited public funding for these procedures.

Lack of Multidisciplinary Care: Successful bariatric surgery outcomes often require a multidisciplinary approach involving surgeons, nutritionists, psychologists, and other healthcare professionals. The lack of access to comprehensive, coordinated care is a barrier to effective treatment.

Patient Concerns about Efficacy and Safety: Some patients hesitate to undergo bariatric surgery due to concerns about the long-term efficacy of the procedures or fears about potential safety risks. These concerns act as a restraint on the market.

Regulatory Landscape and Reimbursement Scenario

In Brazil, bariatric medical devices are regulated by ANVISA (Agência Nacional de Vigilância Sanitária), the national health surveillance agency. ANVISA classifies medical devices into four risk classes, with most bariatric devices falling into higher risk categories. Manufacturers must register their devices with ANVISA, providing technical documentation, clinical evidence, and quality management system certification. The agency conducts rigorous evaluations to ensure safety and efficacy before granting market approval. Post-market surveillance is required, and ANVISA can conduct inspections and request additional studies if necessary.

Brazil has a dual healthcare system: the public Unified Health System (SUS) and private health insurance. Bariatric surgery is covered by SUS for patients meeting specific criteria, typically including a BMI over 40 or over 35 with comorbidities, and failed conservative treatments. However, access through SUS can involve long wait times. Private health insurance plans are required by law to cover bariatric procedures for eligible patients, though coverage details may vary. Patients often need to obtain pre-authorization and may have co-payments. Newer devices or techniques might have limited coverage until they become more established.

Competitive Landscape

Key Players

Here are some of the major key players in the Brazil Bariatric Surgery Devices Market:

• Bhio Supply
• Medicone
• Silimed
• Scitech Medical
• Medicone
• Medtronic plc.
• Ethicon, Inc. (Johnson & Johnson)
• Apollo Endosurgery
• B. Braun
• Spatz FGIA
• Cousin Surgery